Tempus AI Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
14analysts covering
FY Revenue (est.)
$1.6Bnext fiscal year
FY EPS (est.)
-$0.26next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 4 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Diagnostics Revenue Growth Quarterly3,470.0%
Data and Applications Revenue Growth Quarterly4,050.0%
Adjusted EBITDA Quarterly-2.8M
Minimal Residual Disease (MRD) Test Volume Quarterly6.5K
Research as of 2 Sep 2026